Keyphrases
Emergent Adults
100%
Syndemic Framework
100%
Adult Men
100%
High-risk Human Papillomavirus (HR-HPV)
100%
Herpes Simplex Virus Infection
100%
Young MSM
90%
Herpes Simplex Virus 2 (HSV-2)
60%
Herpes Simplex Virus Type 1 (HSV-1)
60%
Papillomavirus Infections
50%
Risk Factors
50%
Herpes Simplex Virus
30%
Diverse Sample
30%
Human Papillomavirus Vaccine
30%
Co-infection
30%
Virus Persistence
20%
Epidemiology
20%
Racial Disparities
20%
Correlating Factors
20%
Vaccine Completion
20%
Vaccine Uptake
20%
Disparities in HIV
20%
Ethnically Diverse
20%
Sexually Transmitted Infections
10%
HIV Susceptibility
10%
HIV Acquisition Risk
10%
Anal Cancer
10%
Syndemic Theory
10%
Gonorrhea
10%
Bacterial Sexually Transmitted Infections
10%
Cytokine Levels
10%
Immunological Response
10%
Vaccine-preventable Diseases
10%
Viral
10%
Syphilis
10%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
10%
Race-ethnicity
10%
HIV Acquisition
10%
Depth Interviews
10%
Monoinfection
10%
Low Risk
10%
Viral Infection
10%
Vaccine Types
10%
Soluble Cytokines
10%
Non-live Vaccines
10%
Microenvironment
10%
Men Who Have Sex with Men
10%
Theory Framework
10%
Health Burden
10%
Biological Mechanisms
10%
HIV Transmission Risk
10%
High Risk
10%
HIV Risk
10%
Chlamydia
10%
Oral Cancer
10%
Ancillary
10%
Sexual Health Care
10%
HIV Burden
10%
Infection Rate
10%
HIV Infection
10%
Medicine and Dentistry
Herpes Simplex Virus
100%
Virus Infection
100%
Wart Virus
100%
Herpes Simplex Virus 2
33%
Human Alphaherpesvirus 1
33%
Human Immunodeficiency Virus
33%
Mixed Infection
16%
Cohort Analysis
16%
Prevalence
16%
Cohort Effect
11%
Infection
11%
Persistent Virus Infection
11%
Chlamydiae
5%
Ethnic Disparity
5%
Human Immunodeficiency Virus Risk Behavior
5%
Gonorrhea
5%
Human Immunodeficiency Virus Infection
5%
Racial Disparity
5%
Cytokine
5%
Oral Cancer
5%
Syphilis
5%
Health Care
5%
Men Who Have Sex with Men
5%
Study Participant
5%
Anal Cancer
5%
Immunology and Microbiology
Herpes Simplex Virus
100%
Viral Disease
100%
Wart Virus
100%
Human Immunodeficiency Virus
38%
Herpes Simplex Virus 2
33%
Human Alphaherpesvirus 1
33%
Coinfection
16%
Prevalence
16%
Vaccination
16%
Human Immunodeficiency Virus Infection
5%
Cytokine
5%
Chlamydiae
5%